Some promising news coming from the Moderna vaccine trial. Researchers say it appears to create a strong immune response in older people, as well as younger adults.
Credit: KTNV Channel 13 Las Vegas Duration: 00:21Published
Results from an early safety study of Moderna's coronavirus vaccine candidate in older adults showed that it produced virus-neutralizing antibodies at levels similar to those seen in younger adults,..
Hyderabad-based pharma company Bharat Biotech to conduct phase 3 clinical trial tests in October. Uttar Pradesh Health Minister Jai Pratap Singh said around 3,000 people to be tested under the phase 3..
Credit: HT Digital Content Duration: 02:29Published